Farxiga Approval Expands Use to More Patients With Heart Failure
Dapagliflozin is sodium-glucose cotransporter 2 inhibitor.
Dapagliflozin is sodium-glucose cotransporter 2 inhibitor.
The risk of hematocrit elevation may depend on testosterone therapy’s route of administration, according to investigators.
Investigators report no significant improvement in cardiovascular or overall mortality in patients on dialysis.
Investigators report promising results with an AI algorithm that can identify and distinguish between 2 heart conditions that challenge even expert cardiologists.
Researchers sought to evaluate incidence of in-hospital cardiac arrest and mortality in children with cardiac disease admitted to the ICU.
A study was conducted to determine short- and long-term risk for cardiovascular disease and mortality in patients with a medical history of COVID-19.
A study was conducted to determine the effect of depression and poor mental health on cardiovascular health in younger adults in the United States.
Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.
Olezarsen is an investigational LICA antisense medication designed to inhibit the production of apoC-III for patients at risk of disease due to elevated triglyceride levels.
Furoscix is a pH-neutral formulation of furosemide, a loop diuretic, designed for SC administration via an on-body infusor for outpatient self-administration.